Sale!

IgH MM FISH Test

Original price was: $176.Current price is: $132.

-25%

The IgH MM FISH Test is a specialized genetic analysis that detects chromosomal abnormalities in the immunoglobulin heavy chain (IgH) gene, crucial for diagnosing and managing Multiple Myeloma. This test uses Fluorescence In Situ Hybridization (FISH) technology to identify specific genetic rearrangements that drive cancer progression. Patients with suspected Multiple Myeloma, unexplained bone pain, anemia, or kidney dysfunction should consider this test. The analysis provides critical information for treatment selection, prognosis assessment, and monitoring disease progression. Results help oncologists develop personalized treatment strategies and predict treatment response. The test costs $132 USD with a regular price of $176 USD, offering significant savings for comprehensive genetic evaluation. Available at our nationwide locations with results in 3-4 days.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

IgH MM FISH Test: Comprehensive Multiple Myeloma Genetic Analysis

Understanding the IgH MM FISH Test

The IgH MM FISH Test represents a cutting-edge diagnostic approach for Multiple Myeloma, a complex plasma cell cancer affecting thousands of Americans annually. This specialized genetic analysis focuses on the immunoglobulin heavy chain (IgH) gene, which plays a pivotal role in the development and progression of Multiple Myeloma. By utilizing advanced Fluorescence In Situ Hybridization (FISH) technology, our test provides unprecedented insights into the genetic landscape of this challenging hematologic malignancy.

What Makes This Test Essential?

Multiple Myeloma is characterized by abnormal plasma cells that accumulate in the bone marrow, disrupting normal blood cell production and causing bone damage. The IgH MM FISH Test specifically targets genetic abnormalities involving the IgH gene locus on chromosome 14, where approximately 50-60% of Multiple Myeloma cases exhibit significant rearrangements. These genetic alterations are not random events but rather critical drivers of disease pathogenesis that influence treatment response and overall prognosis.

What the IgH MM FISH Test Measures

Our comprehensive FISH analysis detects several critical genetic abnormalities:

  • IgH Translocations: Identifies specific partner chromosomes involved in IgH rearrangements, including t(4;14), t(11;14), t(14;16), and t(14;20)
  • Chromosomal Deletions: Detects loss of genetic material, particularly chromosome 13 deletions
  • Amplification Events: Identifies gene duplications that may drive aggressive disease
  • Complex Rearrangements: Uncovers multiple genetic abnormalities that impact treatment decisions

Technical Methodology

The test employs state-of-the-art FISH technology using specific DNA probes that bind to the IgH gene region and its common translocation partners. This allows for precise visualization of genetic abnormalities at the chromosomal level, providing results with exceptional accuracy and reliability.

Who Should Consider the IgH MM FISH Test?

This test is recommended for individuals experiencing:

  • Unexplained bone pain, particularly in the back or ribs
  • Persistent fatigue and unexplained anemia
  • Recurrent infections or compromised immune function
  • Kidney dysfunction or elevated creatinine levels
  • High calcium levels detected in blood tests
  • Abnormal protein levels in blood or urine
  • Family history of Multiple Myeloma or related blood disorders
  • Existing diagnosis of MGUS (Monoclonal Gammopathy of Undetermined Significance)

Clinical Indications

Oncologists typically recommend this test for patients with suspected Multiple Myeloma, those requiring risk stratification at diagnosis, individuals needing treatment response assessment, and patients being evaluated for stem cell transplantation eligibility.

Benefits of Taking the IgH MM FISH Test

  • Personalized Treatment Planning: Genetic results guide targeted therapy selection
  • Accurate Prognosis Assessment: Identifies high-risk versus standard-risk disease
  • Early Intervention Opportunities: Enables timely treatment before complications develop
  • Monitoring Disease Progression: Tracks genetic changes over time
  • Informed Clinical Decisions: Provides evidence-based guidance for treatment intensity
  • Family Risk Assessment: Helps evaluate genetic predisposition in relatives

Impact on Treatment Outcomes

Patients who undergo IgH MM FISH testing typically experience better treatment outcomes due to personalized therapy approaches. The genetic information obtained allows oncologists to select medications that specifically target the identified abnormalities, potentially improving response rates and survival outcomes.

Understanding Your Test Results

Your IgH MM FISH test results will be carefully interpreted by our team of board-certified genetic specialists and hematologists. Results typically fall into several categories:

Normal Results

A normal result indicates no detectable IgH gene rearrangements or significant chromosomal abnormalities. This finding may suggest standard-risk disease with potentially better response to conventional therapies.

Abnormal Results

Specific genetic findings carry different prognostic implications:

  • t(11;14): Generally associated with standard-risk disease and good treatment response
  • t(4;14): Considered high-risk, often requiring more aggressive treatment approaches
  • t(14;16) or t(14;20): High-risk features that may influence treatment selection
  • Chromosome 13 Deletions: May impact prognosis and treatment decisions

Clinical Correlation

It’s important to understand that test results should always be interpreted in the context of your complete clinical picture, including symptoms, laboratory findings, and imaging studies. Your healthcare provider will integrate this genetic information with other clinical data to develop the most appropriate treatment plan.

Test Pricing and Availability

Test Component Price (USD)
Discount Price $132
Regular Price $176

Test Specifications

  • Turnaround Time: 3-4 days
  • Sample Type: Bone Marrow / Peripheral blood
  • Test Components: Sodium Heparin Vacutainer (2ml)
  • Pre-test Instructions: Requires Doctor’s prescription (not applicable for surgery, pregnancy, or travel abroad cases)

Nationwide Accessibility

We proudly serve patients across the United States with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our state-of-the-art facilities ensure consistent, high-quality testing regardless of location.

Convenient Testing Process

Our streamlined testing process begins with a simple sample collection at one of our nationwide locations. Samples are immediately processed using standardized protocols to ensure accuracy and reliability. Results are delivered through secure electronic systems directly to your healthcare provider.

Take Control of Your Health Today

Don’t let uncertainty about your genetic risk factors delay proper diagnosis and treatment. The IgH MM FISH Test provides critical information that can significantly impact your treatment journey and overall outcomes. Our team of genetic specialists and oncology experts are ready to support you through every step of the testing process.

Ready to Schedule Your Test?

Take the first step toward personalized cancer care. Contact us today to schedule your IgH MM FISH Test and gain the genetic insights needed for optimal treatment planning.

Call or WhatsApp: +1(267) 388-9828

Our genetic counseling team is available to answer your questions and help you understand how this test can benefit your specific situation. Early detection and precise genetic characterization can make a significant difference in your treatment journey.